Related references
Note: Only part of the references are listed.Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
Thorsten Klampfl et al.
BLOOD (2011)
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
Nils H. Thoennissen et al.
BLOOD (2010)
Transcriptional Profiling of Polycythemia Vera Identifies Gene Expression Patterns Both Dependent and Independent from the Action of JAK2V617F
Windy Berkofsky-Fessler et al.
CLINICAL CANCER RESEARCH (2010)
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations
Frank Stegelmann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Molecular aspects of myeloproliferative neoplasms
Francois Delhhommeau et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
Somatic Mutations of IDH1 and IDH2 in the Leukemic Transformation of Myeloproliferative Neoplasms
Anthony Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Molecular Signatures of Quiescent, Mobilized and Leukemia-Initiating Hematopoietic Stem Cells
E. Camilla Forsberg et al.
PLOS ONE (2010)
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Veronique Gelsi-Boyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Alterations of NFIA in chronic malignant myeloid diseases
F. Bernard et al.
LEUKEMIA (2009)
Mutations of ASXL1 gene in myeloproliferative neoplasms
N. Carbuccia et al.
LEUKEMIA (2009)
Oligonucleotide array CGH studies in myeloproliferative neoplasms: Comparison with JAK2V617F mutational status and conventional chromosome analysis
Ayalew Tefferi et al.
LEUKEMIA RESEARCH (2009)
JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
Mark A. Dawson et al.
NATURE (2009)
Acquired mutations in TET2 are common in myelodysplastic syndromes
Saskia M. C. Langemeijer et al.
NATURE GENETICS (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A role for JAK2 mutations in myeloproliferative diseases
Kelly J. Morgani et al.
ANNUAL REVIEW OF MEDICINE (2008)
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Ralph Tiedt et al.
BLOOD (2008)
JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
Isabelle Plo et al.
BLOOD (2008)
MLLT3 regulates early human erythroid and megakaryocytic cell fate
Cristina Pina et al.
CELL STEM CELL (2008)
Cytogenetic studies at diagnosis in polycythemia vera:: clinical and JAK2V617F allele burden correlates
Naseema Gangat et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
Xiaohua Shen et al.
MOLECULAR CELL (2008)
SOCS regulation of the JAK/STAT signalling pathway
Ben A. Croker et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Leukemic blasts in transfon-ned JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation
Alexandre Theocharides et al.
BLOOD (2007)
The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3
Michelle B. Hookham et al.
BLOOD (2007)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
The genome: An outsider's view (vol 2, pg 1499, 2006)
Carl Zimmer
PLOS COMPUTATIONAL BIOLOGY (2007)
Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP Arrays (vol 2, pg 323, 2006)
Rameen Beroukhim et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
Jak2: normal function and role in hematopoietic disorders
James N. Ihle et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Molecular profiling of CD34(+) cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1)
Paola Guglielmelli et al.
STEM CELLS (2007)
Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
Linda M. Scott et al.
BLOOD (2006)
X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and NIMM patients with clonal hematopoiesis
Ross L. Levine et al.
BLOOD (2006)
Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays
Rameen Beroukhim et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects
C James et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
R Kralovics et al.
BLOOD (2005)
Identification of an acquired JAK2 mutation in Polycythemia vera
RX Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells
E Tenedini et al.
BLOOD (2004)
Circular binary segmentation for the analysis of array-based DNA copy number data
AB Olshen et al.
BIOSTATISTICS (2004)
Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders
R Kralovics et al.
BLOOD (2003)
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera
R Kralovics et al.
EXPERIMENTAL HEMATOLOGY (2002)
Cytogenetic and molecular genetic aspects of essential thrombocythemia
DP Steensma et al.
ACTA HAEMATOLOGICA (2002)
Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia
A Tefferi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Requirement for p38α in erythropoietin expression:: A role for stress kinases in erythropoiesis
K Tamura et al.
CELL (2000)
Share Paper
